Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
8.97
-0.26 (-2.77%)
Aug 11, 2025, 1:38 PM - Market open
Paramount Global Market Cap
Organon & Co. has a market cap or net worth of $2.33 billion as of August 11, 2025. Its market cap has decreased by -58.10% in one year.
Market Cap
2.33B
Enterprise Value
10.81B
1-Year Change
-58.10%
Ranking
Category
Stock Price
$8.97
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.33B, a decrease of -72.31%. That is a compound annual growth rate of -26.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 2.40B | -37.62% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 582.63B |
| Johnson & Johnson | 419.00B |
| AbbVie | 349.00B |
| UnitedHealth Group | 233.76B |
| Abbott Laboratories | 229.04B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |